Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Contents

Current Drug Targets, Volume 17 - Number 9



From “An Enzyme Able to Destroy Penicillin” to Carbapenemases: 70 Years of Beta-lactamase Misbehaviour

, 17(9): 974 - 982

Jean-Marie Frère, Eric Sauvage and Frédéric Kerff


DOI: 10.2174/1389450116666151001112859



Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore

, 17(9): 983 - 1005

Donatella Tondi, Simon Cross, Alberto Venturelli, Maria P. Costi, Gabriele Cruciani and Francesca Spyrakis


DOI: 10.2174/1389450116666151001104448







Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art

, 17(9): 1072 - 1082

Magdalena Witkowska and Piotr Smolewski


DOI: 10.2174/1389450116666150907105306



MicroRNAs in Breast Cancer: One More Turn in Regulation

, 17(9): 1083 - 1100

Pilar E. Asensio, Eduardo T. Martin, Begona P. Merlo, Estefanía E. Armas and Ana L. Hernández


DOI: 10.2174/1389450116666150213114103




Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog